Products

ItineraryFlow

Uses AI

From trip planning to booked trips

itineraryflow.com Travel & Transportation / Trip Planning

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$19/mo
Higher than 83% of peersNiche median $6/mo
Creators
Sebastien Augustin
No social account linked
Launched
5mo ago
2026-06-16 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions

  • Launched on Product HuntLaunch

    Easily create amazing trip Itineraries

    Jun 16 · 5mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-05-28

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

One plan
$19/mo
Unlimited clients & trips

Trial: 7-day free trial · 1 paid tier ($19) · Observed 2026-10-31 · Source page

Entry price $19/mo, Higher than 83% of peers; “Trip Planning” median is $6/mo.View pricing benchmark

Pages & changes

Tracked since 2026-06-16

Key pages

Weekly snapshots
Home
www.itineraryflow.com/ Snapshot 2026-11-03

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does ItineraryFlow cost?
One plan: $19/mo. Observed 2026-10-31. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does ItineraryFlow get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ItineraryFlow and what platforms does it support?
ItineraryFlow is catalogued under Trip Planning: From trip planning to booked trips. Supported platforms: Web.

Related products in this category

Travel & Transportation / Trip Planning

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.